Chad E. Kennedy’s experience spans biomedical engineering and biotechnology research, project management and advanced technology integration and application in industry. Mr. Kennedy’s expertise stems from spending the last 15-plus years working in the field of biomedical engineering from all sides:
Earlier in his career, Mr. Kennedy helped establish Silicon Valley operations of VI Technology, Inc., an Austin based automation technology consulting firm. He was responsible for acquiring, developing and managing consulting projects, integrating hardware and software applications for high-end test and automation systems for cross-discipline technologies. Prior to VI Tech, he worked in various engineering design, testing and astronaut training capacities at NASA Johnson Space Center in Houston, Texas.
Mr. Kennedy is currently the chair and assistant professor of the Biomedical Engineering Technology Program at DeVry University and an adjunct faculty of bioengineering at Arizona State University.
In the Community
Past positions include service as Workforce Development Committee Co-Chair on the Arizona Bioindustry Association - Greater Phoenix Board.
Mr. Kennedy was the co-founder, president and chief executive officer of the start-up company, Restorative Biosciences Inc., an early stage company that focuses on developing anti-fouling, anti-inflammatory coatings and therapeutics for ophthalmic applications.
Like his professional background, Mr. Kennedy’s research also spans the entire spectrum of the professional world. Currently, Mr. Kennedy is: reviewing whether technological advancements in medical imaging reduces health care costs, examining effective approaches of engineering education and exploring robotic systems with functions in bioengineering and biomedical engineering.
Mr. Kennedy is also preparing to present a pathway model for those who can reconcile scientific logic with purposeful existence in his first book, a look at how scientific evidence and spiritual philosophy are merging.
Mr. Kennedy holds both a bachelor’s degree in mechanical engineering from the University of Texas (Austin) in addition to both a master’s degree and his doctorate in biomedical engineering from Arizona State University.
- There is an ever-increasing reliance on technology in the medical field, which is good for the biomedical device industry. With the increasing healthcare costs and the social, political and economic pressures to keep them contained, there will be increased scrutiny on the hospitals to justify expensive new devices as a net cost savings and improved healthcare delivery. Many systems will not pass the litmus test and some will only be justified with higher frequency of usage.
- With the competition of high usage and better patient outcomes, CT systems will eventually need to be replaced with a non-ionizing equivalent due to the limitations of radiation exposure. MRI is an excellent alternate; however, there are other safety limitations for these systems. This may be 20 years out to get an equivalent replacement that is not MRI.
- Radiation therapies will need to transform to safer and more directed technologies, since there is some rising speculation that some radiation therapy systems may temporarily suppress a cancer into remission, only to have a new cancer reemerge as a result of the treatment itself.
- Eventually, many biomarker tests, blood, breath and urine analysis that are currently done at large labs or require a doctor or specialist visit will be available over the counter and performed at home. The results can then be uploaded to your personal electronic medical record, which your primary physician or specialist can review and recommend treatment.
To schedule an interview with Chad Kennedy, please contact Katie Pearson at 312-861-5248 or email@example.com.